Start-up
Predemtec AG
catching early signals
About Predemtec
We are a company focused on the research, development and manufacturing of innovative diagnostic tests to determine risk factors of dementia-related diseases.
We have set ourselves the goal of being able to diagnose the various forms of dementia earlier and more reliably through the innovative diagnostic tests we have developed. This is because only when detected early can dementia therapy be used effectively and efficiently to delay the manifestation of the disease and mitigate its severity.
Our first test, Predemtec DX, is a serum-based immunoassay for the early and risk diagnosis of senile dementia of the Alzheimer's type.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Founding: 2011
- Focus : Manufacturer
- Industry : Diagnostics
News about Predemtec
Here you will find Predemtec AG
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
